Ecolab INC

Based in DC

🤖

AI Overview

With $10.3M in lobbying spend across 36 quarterly filings, Ecolab INC is one of the biggest lobbying spenders in Washington. Their lobbying covers 16 issue areas. Active from 2018 to 2025.

$10.3M
Total Spend
8
Years Active
1
Firms Hired
5
Lobbyists Deployed
16
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$1.8M
2019$1.1M
2020$830K
2021$1.0M
2022$1.1M
2023$1.1M
2024$1.4M
2025$2.1M

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Ecolab INC disclosed contacting in their lobbying filings.

Commerce, Dept of (DOC)Energy, Dept ofEnvironmental Protection Agency (EPA)HOUSE OF REPRESENTATIVESNatl Economic Council (NEC)SENATEState, Dept of (DOS)Treasury, Dept ofExecutive Office of the President (EOP)Natl Security Council (NSC)U.S. Trade Representative (USTR)Agriculture, Dept of (USDA)White House OfficeHealth & Human Services, Dept of (HHS)Transportation, Dept of (DOT)Federal Aviation Administration (FAA)Food & Drug Administration (FDA)Office of Science & Technology Policy (OSTP)Export-Import Bank of the United States (EXIM Bank)Interior, Dept of (DOI)
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Trade, Health Issues, Food Industry, Foreign Relations, Homeland Security and 11 more

Trade issues and international items.

Cosmetic safety legislation including: H.R.575, Cosmetic Modernization Amendments of 2017 and S.1113, Personal Care Product Safety Act.

OTC monograph legislation; implementation of the Food Safety Modernization Act (FSMA); cleaning product labeling.

Issues related to international sanctions legislation.

Issues related to cybersecurity.

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.